LOSS OF RESPONSE AND DOSE ESCALATION OF INFLIXIMAB AND ADALIMUMAB IN ULCERATIVE COLITIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Edo Savelkoul 1
Pepijn Thomas 1
Lauranne Derikx 1
Nathan Den Broeder 1
Tessa E.H. Römkens 2
Frank Hoentjen 3
1 Radboudumc, Nijmegen, Netherlands
2 Jeroen Bosch Hospital, Den Bosch, Netherlands
3 University of Alberta, Edmonton, Canada
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]